Qing Song Health CoLtd
6931.TWO
TWD68.30 0.15%
Exchange: TWO | Sector: Healthcare | Industry: Medical Care Facilities
Q2 2024
Published: Jun 30, 2024

Earnings Highlights

  • Revenue of $235.77M up 15.6% year-over-year
  • EPS of $0.16 decreased by 27.3% from previous year
  • Gross margin of 11.8%
  • Net income of 9.56M
  • "" -
6931.TWO
Company 6931.TWO

Executive Summary

Qing Song Health CoLtd reported QQ2 2024 revenue of 235.77 million TWD, up 15.6% year over year, supported by solid occupancy and service demand in Taiwan’s long-term care market. Despite top-line growth, net income declined approximately 28% YoY to 9.56 million TWD, driven by factors including depreciation, interest and non-operating items, and a higher tax base, resulting in a net margin of about 4.06% and an EPS of 0.16 TWD. The company generated positive operating cash flow of 62.15 million TWD and free cash flow of ~29.98 million TWD, underscoring cash-generation capability from core operations. However, leverage remains a material consideration: total debt stood at ~1,057.31 million TWD with long-term debt accounting for ~977.76 million and a debt-to-capitalization of ~62.5%, highlighting balance sheet risk that investors should monitor alongside occupancy-driven revenue volatility.

Key Performance Indicators

Revenue
Increasing
235.77M
QoQ: 0.00% | YoY: 15.61%
Gross Profit
Increasing
27.78M
11.78% margin
QoQ: 0.00% | YoY: 19.91%
Operating Income
Increasing
9.74M
QoQ: 0.00% | YoY: 24.13%
Net Income
Decreasing
9.56M
QoQ: 0.00% | YoY: -28.20%
EPS
Decreasing
0.16
QoQ: 0.00% | YoY: -27.27%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 564.77 0.72 +139.5% View
Q1 2025 258.05 -0.05 +12.0% View
Q3 2024 254.60 0.13 +10.5% View
Q2 2024 235.77 0.16 +15.6% View